Antibiotic susceptibility reports
Susceptibility data for aerobic Gram positive and Gram negative organisms
Below is the 2022 antibiotic susceptibility data for aerobic Gram positive and Gram negative organisms, isolated from clinical specimens sent to the Microbiology department of LabPLUS. It includes single patient isolates from Te Toka Tumai Auckland - Auckland City Hospital, Starship Hospital, Greenlane Clinical Centre as well as referred isolates from other hospitals in the Auckland region.
View or download the 2022 antimicrobial reports:
- Gram positive antibiotic susceptibility data [PDF, 216 KB]
- Gram negative antibiotic susceptibility data [PDF, 637 KB]
Specimens include sterile sites specimens such as blood cultures, cerebrospinal fluid (CSF) and aspirates, as well as non sterile site specimens such as respiratory specimens, urine, wound swabs etc. However the data on Streptococcus pneumoniae are only shown for blood cultures and CSF isolates.
ESR Communicable Disease surveillance reports(external link) website has national data for Streptococcus pneumoniae and Neisseria meningitidis.
The organisms included in the data are commonly implicated in community and nosocomial acquired infections in our setting. The antibiotics tested and reported for each organism, follow recommendations and standards/methods outlined by EUCAST (European Commitee on Antimicrobial Susceptibility Testing).
Susceptibility data for anaerobic Gram positive and Gram negative organisms
This is the 2011 anaerobic bacteria susceptibility patterns data for Gram positive and Gram negative anaerobic organisms. The organisms were isolated over the last 8 years from clinical specimens from Auckland City Hospital, Starship Children’s Hospital, and referred isolates from other New Zealand hospitals.
This data has been presented at Australian Society for Antimicrobials 13th Annual Scientific Meeting, Antimicrobials 2012, 23rd-25th February 2012, Brisbane, Australia.
Susceptibility data for yeast and mould isolates
This is the 2001 to 2019 antifungal susceptibility data derived from local and referred clinical isolates from other New Zealand laboratories. Isolates recovered from wide range of clinical specimens.